Key result
Post-percutaneous coronary intervention angina affects up to 30% of patients and requires an individualized pharmacological approach targeting specific physiopathological mechanisms to optimize symptom relief.
Why the study?
Despite complete or incomplete PCI, patients with chronic IHD may still experience recurrent anginal symptoms that impair quality of life and prognosis.
Post-PCI angina is a frequent and often neglected condition that requires careful functional evaluation and optimization of individualized anti-anginal medical therapy.
Persistent post-PCI angina warrants tailored management; leaves open mechanism-specific trials before practice change.
Chronic ischemic heart disease (IHD) is a multifactorial disease with different underlying pathogenetic mechanisms. Percutaneous coronary intervention (PCI) is widely used in patients with IHD in order to reduce angina recurrence. However, after complete or incomplete revascularization procedures, patients may still present anginal symptoms, with a detrimental impact on quality of life and prognosis. This review summarizes the pathogenic mechanisms and the main challenges encountered in the diagnosis and management of post-PCI angina.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2021) conducted a review in Post-percutaneous coronary intervention (PCI) angina. Individualized anti-anginal therapy was evaluated. Post-percutaneous coronary intervention angina affects up to 30% of patients and requires an individualized pharmacological approach targeting specific physiopathological mechanisms to optimize symptom relief.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: